Your browser doesn't support javascript.
loading
WISP2/CCN5 Suppresses Vasculogenic Mimicry through Inhibition of YAP/TAZ Signaling in Breast Cancer Cells.
Ferrand, Nathalie; Fert, Aude; Morichon, Romain; Radosevic-Robin, Nina; Zaoui, Maurice; Sabbah, Michèle.
Afiliação
  • Ferrand N; Team Cancer Biology and Therapeutics, Centre de Recherche Saint-Antoine (CRSA), Institut Universitaire de Cancérologie, Sorbonne University, Inserm UMR_S 938, 75012 Paris, France.
  • Fert A; Team Cancer Biology and Therapeutics, Centre de Recherche Saint-Antoine (CRSA), Institut Universitaire de Cancérologie, Sorbonne University, Inserm UMR_S 938, 75012 Paris, France.
  • Morichon R; CRSA Cytométrie Imagerie Saint-Antoine, Sorbonne University, 75012 Paris, France.
  • Radosevic-Robin N; Centre Jean Perrin, Department of Pathology, University Clermont Auvergne, INSERM U1240 (IMoST), 63011 Clermont-Ferrand, France.
  • Zaoui M; Team Cancer Biology and Therapeutics, Centre de Recherche Saint-Antoine (CRSA), Institut Universitaire de Cancérologie, Sorbonne University, Inserm UMR_S 938, 75012 Paris, France.
  • Sabbah M; Team Cancer Biology and Therapeutics, Centre de Recherche Saint-Antoine (CRSA), Institut Universitaire de Cancérologie, Sorbonne University, Inserm UMR_S 938, 75012 Paris, France.
Cancers (Basel) ; 14(6)2022 Mar 14.
Article em En | MEDLINE | ID: mdl-35326638
ABSTRACT
Vasculogenic mimicry (VM) formed by aggressive tumor cells to create vascular networks connected with the endothelial cells, plays an important role in breast cancer progression. WISP2 has been considered as a tumor suppressor protein; however, the relationship between WISP2 and VM formation remains unclear. We used the in vitro tube formation assay and in vivo immunohistochemical analysis in a mouse model, and human breast tumors were used to evaluate the effect of WISP2 on VM formation. Here we report that WISP2 acts as a potent inhibitor of VM formation in breast cancer. Enforced expression of WISP2 decreased network formation while knockdown of WISP2 increased VM. Mechanistically, WISP2 increased retention of oncogenic activators YAP/TAZ in cytoplasm, leading to decreased expression of the angiogenic factor CYR61. Studies using an in vivo mouse model and human breast tumors confirmed the in vitro cell lines data. In conclusion, our results indicate that WISP2 may play a critical role in VM and highlight the critical role of WISP2 as a tumor suppressor.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França